Human medicines European public assessment report (EPAR): Silgard, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Condylomata Acuminata,Immunization, Date of authorisation: 19/09/2006, Revision: 33, Status: Withdrawn
Keyword(s):
Adjuvant Human Papillomavirus Vaccine to Reduce Recurrent Cervical Dysplasia in Unvaccinated Women
Keyword(s):
